Lord, Abbett & Co’s Pliant Therapeutics PLRX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | – | Sell |
-455,823
| Closed | -$8.26M | – | 570 |
|
2023
Q2 | $8.26M | Sell |
455,823
-1,030,347
| -69% | -$18.7M | 0.03% | 435 |
|
2023
Q1 | $39.5M | Buy |
1,486,170
+985,382
| +197% | +$26.2M | 0.14% | 220 |
|
2022
Q4 | $9.68M | Buy |
500,788
+1,255
| +0.3% | +$24.3K | 0.03% | 428 |
|
2022
Q3 | $10.4M | Buy |
499,533
+180,774
| +57% | +$3.78M | 0.04% | 399 |
|
2022
Q2 | $2.55M | Buy |
318,759
+21,725
| +7% | +$174K | 0.01% | 533 |
|
2022
Q1 | $2.08M | Buy |
297,034
+5,220
| +2% | +$36.6K | 0.01% | 584 |
|
2021
Q4 | $3.94M | Sell |
291,814
-2,843
| -1% | -$38.4K | 0.01% | 566 |
|
2021
Q3 | $4.97M | Sell |
294,657
-3,936
| -1% | -$66.4K | 0.01% | 597 |
|
2021
Q2 | $8.7M | Sell |
298,593
-28,501
| -9% | -$830K | 0.02% | 551 |
|
2021
Q1 | $12.9M | Buy |
327,094
+137,690
| +73% | +$5.42M | 0.03% | 486 |
|
2020
Q4 | $4.3M | Sell |
189,404
-4,302
| -2% | -$97.7K | 0.01% | 603 |
|
2020
Q3 | $4.39M | Buy |
+193,706
| New | +$4.39M | 0.01% | 576 |
|